Fifth Third Bancorp’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-300
| Closed | -$1K | – | 2780 |
|
|
2022
Q2 | $1K | Buy |
300
+6
| +2% | +$26 | ﹤0.01% | 2618 |
|
|
2022
Q1 | $1K | Buy |
294
+134
| +84% | +$742 | ﹤0.01% | 2645 |
|
|
2021
Q4 | $1K | Hold |
160
| – | – | ﹤0.01% | 2654 |
|
|
2021
Q3 | $1K | Buy |
+160
| New | +$925 | ﹤0.01% | 2621 |
|
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$24K | – | 2556 |
|
|
2021
Q1 | $24K | Sell |
3,000
-3,000
| -50% | -$24.5K | ﹤0.01% | 1713 |
|
|
2020
Q4 | $39K | Sell |
6,000
-143
| -2% | -$834 | ﹤0.01% | 1475 |
|
|
2020
Q3 | $22K | Buy |
6,143
+143
| +2% | +$577 | ﹤0.01% | 1554 |
|
|
2020
Q2 | $28K | Sell |
6,000
-12,581
| -68% | -$53.5K | ﹤0.01% | 1471 |
|
|
2020
Q1 | $63K | Hold |
18,581
| – | – | ﹤0.01% | 1209 |
|
|
2019
Q4 | $95K | Hold |
18,581
| – | – | ﹤0.01% | 1183 |
|
|
2019
Q3 | $45K | Sell |
18,581
-958
| -5% | -$2.54K | ﹤0.01% | 1391 |
|
|
2019
Q2 | $42K | Buy |
19,539
+958
| +5% | +$2.27K | ﹤0.01% | 1417 |
|
|
2019
Q1 | $50K | Hold |
18,581
| – | – | ﹤0.01% | 1285 |
|
|
2018
Q4 | $89K | Sell |
18,581
-29
| -0.2% | -$176 | ﹤0.01% | 1075 |
|
|
2018
Q3 | $176K | Buy |
18,610
+29
| +0.2% | +$279 | ﹤0.01% | 938 |
|
|
2018
Q2 | $181K | Hold |
18,581
| – | – | ﹤0.01% | 931 |
|
|
2018
Q1 | $195K | Buy |
18,581
+12,581
| +210% | +$124K | ﹤0.01% | 896 |
|
|
2017
Q4 | $38K | Hold |
6,000
| – | – | ﹤0.01% | 1366 |
|
|
2017
Q3 | $46K | Sell |
6,000
-700
| -10% | -$4.65K | ﹤0.01% | 1316 |
|
|
2017
Q2 | $48K | Hold |
6,700
| – | – | ﹤0.01% | 1291 |
|
|
2017
Q1 | $26K | Hold |
6,700
| – | – | ﹤0.01% | 1506 |
|
|
2016
Q4 | $14K | Hold |
6,700
| – | – | ﹤0.01% | 1712 |
|
|
2016
Q3 | $18K | Hold |
6,700
| – | – | ﹤0.01% | 1659 |
|
|
2016
Q2 | $21K | Buy |
6,700
+3,000
| +81% | +$18.8K | ﹤0.01% | 1560 |
|
|
2016
Q1 | $32K | Sell |
3,700
-55
| -1% | -$465 | ﹤0.01% | 1480 |
|
|
2015
Q4 | $51K | Buy |
3,755
+604
| +19% | +$7.43K | ﹤0.01% | 1375 |
|
|
2015
Q3 | $30K | Sell |
3,151
-1,249
| -28% | -$18.3K | ﹤0.01% | 1577 |
|
|
2015
Q2 | $63K | Hold |
4,400
| – | – | ﹤0.01% | 1356 |
|
|
2015
Q1 | $39K | Sell |
4,400
-132
| -3% | -$956 | ﹤0.01% | 1507 |
|
|
2014
Q4 | $28K | Sell |
4,532
-154
| -3% | -$1.41K | ﹤0.01% | 1614 |
|
|
2014
Q3 | $50K | Buy |
4,686
+186
| +4% | +$2.1K | ﹤0.01% | 1393 |
|
|
2014
Q2 | $53K | Buy |
4,500
+38
| +0.9% | +$477 | ﹤0.01% | 1403 |
|
|
2014
Q1 | $67K | Hold |
4,462
| – | – | ﹤0.01% | 1301 |
|
|
2013
Q4 | $65K | Sell |
4,462
-88
| -2% | -$1.35K | ﹤0.01% | 1221 |
|
|
2013
Q3 | $77K | Hold |
4,550
| – | – | ﹤0.01% | 1131 |
|
|
2013
Q2 | $75K | Buy |
+4,550
| New | +$73.7K | ﹤0.01% | 1158 |
|
Other funds holding IMGN
RCM
DM
RG
Fifth Third Bancorp's IMGN Position: Q3 2022 in Review
Fifth Third Bancorp sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 300 shares — an estimated $1K sold.
Fifth Third Bancorp first reported a position in IMGN in Q2 2013 and held it in 36 quarters. The position peaked at $195K in Q1 2018. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.
- Fifth Third Bancorp reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
- Fifth Third Bancorp sold 300 Immunogen Inc shares in Q3 2022, an estimated $1K.
- Fifth Third Bancorp first reported a position in Immunogen Inc in Q2 2013 and held it in 36 quarters.
- Fifth Third Bancorp's Immunogen Inc position peaked at $195K in Q1 2018.
- 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.
Based on Fifth Third Bancorp's 13F filing for Q3 2022, filed 25 Oct 2022.